CAS 1802148-05-5

Formule : C23H24N4O4

InChI : InChI=1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1

Code InChI : AEXFXNFMSAAELR-RXVVDRJESA-N

SMILES : CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)OC1=O

Azd7986

CAS : 1802148-05-5

Formule : C₂₃H₂₄N₄O₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 420.4611

Ref: IN-DA01EOGL

Brensocatib

CAS : 1802148-05-5

Brensocatib

Formule : C₂₃H₂₄N₄O₄

Degré de pureté : ≥95%

Masse moléculaire : 420.46

Ref: 54-BUP04938

Brensocatib

CAS : 1802148-05-5

Brensocatib (AZD7986) is a Dipeptidyl peptidase 1 (DPP1) inhibitor (pIC50s: 6.85, 7.7, 7.6, 7.8, and 7.8 in human, rat, mouse, rabbit, and dog, respectively).

Formule : C₂₃H₂₄N₄O₄

Degré de pureté : 97.55% - 98.69%

Couleur et forme : Solid

Masse moléculaire : 420.46

Ref: TM-TQ0038

Brensocatib (AZD7986)

CAS : 1802148-05-5

Formule : C₂₃H₂₄N₄O₄

Masse moléculaire : 420.47

Ref: 4Z-B-302001

Brensocatib

CAS : 1802148-05-5

Rensocatib is a reversible inhibitor of DPP-1, also known as cathepsin C, which is a peptidase involved in the activation of neutrophil, an elastase-like serine protease in lung tissue. Brensocatib is an oral drug used to treat infections of the airways (lungs) that are characterised by a permanent enlargement and presenting symptoms such as, coughing and greater mucus production (bronchiectasis). Alternative names of brensocatib are INS-1007 and AZD7986.

Formule : C₂₃H₂₄N₄O₄

Degré de pureté : Min. 95 Area-%

Couleur et forme : Powder

Masse moléculaire : 420.46 g/mol

Ref: 3D-BB177302